ASX Share rice
Sat 08 Aug 2020 - 04:45:am (Sydney)

OSL Share Price

ONCOSIL MEDICAL LTDOSLPharmaceuticals, Biotechnology & Life Sciences

OSL Company Information

Name:

OncoSil Medical Limited

Sector:

Healthcare

Industry:

Medical Devices

GIC Industry:

Life Sciences Tools & Services

GIC Sub Industry:

Life Sciences Tools & Services

Address:

50 Berry Street North Sydney NSW Australia 2060

Phone:

61 2 9223 3344

CEO, MD & Exec. Director:

Mr. Daniel Kenny B.Sc.

Chief Financial Officer:

Mr. Karl David Pechmann

Global Sales & Marketing Director:

Mr. Michael Warrener

Global Head of Manufacturing Operations:

Dr. David C. James

Pres of US Operations:

Mr. Charles Rowland

Company Overview:

OncoSil Medical Limited, a medical device company, focuses on the development of localized treatments for pancreatic and liver cancer in Australia. Its lead product is OncoSil, a brachytherapy device that implants a pre-determined dose of beta radiation directly into cancerous tissue for the treatment of cancer. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in June 2013. OncoSil Medical Limited is headquartered in North Sydney, Australia.

OSL Share Price Information

Shares Issued:

676.96M

Market Capitalisation:

$77.85M

Revenue (TTM):

$2.98M

Revenue Per Share (TTM):

$0.01

Earnings per Share:

$-0.014

Profit Margin:

-2.2883

Operating Margin (TTM):

$-2.34

Return On Assets (TTM):

$-0.37

Return On Equity (TTM):

$-0.66

Quarterly Revenue Growth (YOY):

-0.356

Gross Profit(TTM):

$3.63M

Diluted Earnings Per Share (TTM):

$-0.011

OSL CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-14,828

Change To Liabilities:

$-816,440

Total Cashflow From Investing Activities:

$-14,828

Net Income:

$-8,566,731

Total Cash From Operating Activities:

$-7,501,154

Depreciation:

$38.62K

Capital Expenditures:

$14.83K

OSL Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-8,566,731

Net Income:

$-8,566,731

Gross Profit:

$3.63M

Operating Income:

$-12,411,776

Total Revenue:

$3.63M

Total Operating Expenses:

$12.41M

OSL Balance Sheet

Balance Sheet Date:

2019-06-30

Total Liabilities:

$0.99M

Total Stockholder Equity:

$10.68M

Other Current Liabilities:

$304.84K

Total Assets:

$11.67M

Common Stock:

$52.26M

Other Current Assets:

$69.21K

Retained Earnings:

$-47,602,490

Cash:

$7.69M

Total Current Liabilities:

$0.99M

Property - Plant & Equipment:

$62.47K

Net Tangible Assets:

$10.68M

Total Current Assets:

$11.61M

Net Receivables:

$3.82M

Short-Term Investments:

$62.47K

Accounts Payable:

$363.99K

Non Currrent Assets (Other):

$62.47K

Short-Term Investments:

$62.47

Non Current Liabilities Total:

$0

OSL Share Price History

OSL News

30 May, 2020
Whilst it may not be a huge deal, we thought it was good to see that the OncoSil Medical Limited (ASX:OSL...
27 Apr, 2020
Daniel Kenny has been the CEO of OncoSil Medical Limited (ASX:OSL) since 2015. First, this article will compare CEO...
13 Mar, 2020
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...
17 Jan, 2020
When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...
04 Oct, 2019
Just because a business does not make any money, does not mean that the stock will go down. For example, although...